Cooperative Trials Group for Neuro-Oncology (COGNO)

The Cooperative Trials Group for Neuro-Oncology (COGNO) was established in 2007, following identification of a need to develop a central mechanism enabling a coordinated, structured approach to the management of large-scale multi-centered neuro-oncology trials.
Mission:
“The achievement of better health outcomes for patients and those affected by brain tumours through clinical trials research”.

Aims:
• To promote the use of clinical trials in evaluating current therapies, new treatments and supportive interventions for brain tumours and to improve the impact of new clinical trials on future clinical practice.
• To engage members of the medical/scientific community through participation to assist in the conduct, evaluation, promotion and development of clinical trials in brain tumours.
• To promote the incorporation of translational studies into new clinical trials in brain tumours.
• To freely publish the results of research and clinical trials and to make available for general use, on the same terms to all interested bodies, licences for Australian and New Zealand patents issued in the course of research and clinical trials.